SanticxisSanticxisHealth Economics Advisory
The firm

A specialist firm for high-stakes health decisions

Santicxis positions itself as a health economics advisory firm specializing in economic evaluation, HTA, market access, reimbursement strategy, and decision support for governments, institutions, industry, NGOs, and healthcare organizations.

Health economic evaluationHTA and reimbursementMarket accessDecision modelingBudget impact analysisHealth policy

The firm steps in when resources are constrained, innovations are costly, and decisions must be scientifically robust, economically defensible, and institutionally clear for payers, authorities, funders, and public partners.

Its approach combines advanced economic modeling, pharmacoeconomics, data analysis, health policy expertise, and a strong understanding of African, Canadian, and emerging health systems.

Firm signature
  • Economic evaluation and modeling
  • Health policy and resource allocation
  • Africa, francophone systems, and emerging markets

Recognized expertise

More than 12 years of combined experience in economic analysis, modeling, and health decision support, backed by multidisciplinary profiles.

Scientific rigor

Methods aligned with international standards to produce reliable, auditable, decision-ready analyses.

Tailored approach

Each engagement is designed around the client’s constraints, country context, payer environment, or institutional reality.

Founder

Christian Kouakou, PhD

Health economist, researcher, and advisor, Christian Kouakou helps decision-makers optimize healthcare investments across francophone and resource-constrained settings.

His work focuses on the economic value of health, QALYs, health technology assessment, and decision-oriented modeling.

His publications in journals such as European Journal of Health Economics, Value in Health, BMJ Open, and IJERPH reinforce the firm’s scientific credibility.

Useful research

Expertise grounded in published work and methods aligned with international standards.

Decision focus

A strong ability to connect analytical rigor with real payer, regulator, and institutional trade-offs.

Francophone and international reach

A nuanced understanding of health system needs in Africa, Canada, and emerging markets.

We work notably with

We work notably with

Pharmaceutical and biotech companies

Economic value demonstration, pricing strategy, market access, and reimbursement support.

Government organizations

Budget impact, efficiency, equity, and public health prioritization analyses.

NGOs and funders

Assessment of program impact and economic sustainability, with stronger funding cases.

Hospitals and research institutes

Support in study design, data management, and modeling to demonstrate intervention value.

Selected projects & institutional engagements

Selected Projects & Institutional Engagements

Selected engagements include academic and policy collaborations in Canada and Africa, with a focus on economic evaluation, applied data analysis, and decision support.

Université de Sherbrooke - Faculty of Medicine and Health Sciences (FMSS)

Health Economics Research Support

Ongoing collaboration around the economic evaluation of a multimodal prehabilitation program designed for older adults, within an academic and clinical environment.

  • Economic framing of the program and expected outcomes
  • Analytical support to document value and efficiency
  • Contribution to research and decision-oriented interpretation
CIRANO, in collaboration with a Quebec ministry

Policy-Oriented Economic Analysis

Ongoing contribution to a project assessing the costs and benefits of urban green infrastructure, with a population health and climate adaptation perspective.

  • Economic analysis of costs and benefits
  • Structuring of evidence to support public decision-making
  • Integration of population health and climate adaptation perspectives
Université du Québec en Abitibi-Témiscamingue (UQAT)

Health Outcomes and Quality of Life Analysis

Analytical support for a study on physical activity and health-related quality of life among men with prostate cancer living in remote regions of Quebec.

  • Applied data analysis for a public health research project
  • Interpretation of results and support for empirical research work
  • Contribution to understanding quality-of-life determinants in remote settings
Let’s talk

Let’s discuss your strategic healthcare priorities.

Need support with health economic evaluation, market access strategy, reimbursement strategy, budget impact analysis, HTA, or a high-level training program? Let’s define the intervention that will be the most credible, useful, and operational.